All Stories

  1. Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users
  2. Higher Myonuclei Density in Muscle Fibers Persists Among Former Users of Anabolic Androgenic Steroids
  3. The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes
  4. Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
  5. Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial
  6. Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
  7. Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes
  8. Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial
  9. 9-03: Aair vs. dddr in sick sinus syndrome. extended follow-up in danpace
  10. OUP accepted manuscript